Home / IL-15R alpha / Recombinant Mouse IL-15R alpha Fc Chimera Protein, CF

Recombinant Mouse IL-15R alpha Fc Chimera Protein, CF

Catalog #: 551-MR
41 Citations 1 Review Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
551-MR-100
Best Seller
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (41)
FAQs
Supplemental Products
Reviews (1)
Summary Product Datasheets Carrier Free Data Images Reconstitution Calculator Background Related Research Areas

Recombinant Mouse IL-15R alpha Fc Chimera Protein, CF Summary

Product Specifications

Accession #
Q60819
N-terminal Sequence
Analysis
Gly33
Structure / Form
Disulfide-linked homodimer
Predicted Molecular Mass
44.9 kDa (monomer)
SDS-PAGE
80-90 kDa, 42 kDa and 35 kDa, reducing conditions

Product Datasheets

You must select a language.

x

551-MR

Product Datasheet
COA
SDS

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

551-MR

Formulation Lyophilized from a 0.2 μm filtered solution in PBS.
Reconstitution Reconstitute at 100 μg/mL in sterile PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: IL-15R alpha

Interleukin 15 Receptor alpha (IL 15 R alpha ), also known as CD215, is a widely expressed 60 kDa transmembrane glycoprotein that plays an important role in the homeostasis and activation of NK cells and CD8+ memory T cells and participates in the development and function of many other hematopoietic cell types and non‑immune cell types (1 ‑ 3). Mature mouse IL‑15 R alpha consists of a 173 aa extracellular domain (ECD) containing one N‑linked glycosylation site, a 21 aa transmembrane segment, and a 37 aa cytoplasmic tail (4). Within the ECD, mouse IL‑15 R alpha shares 59% and 89% aa sequence identity with human and rat IL‑15 R alpha, respectively. Alternate splicing of mouse IL‑15 R alpha generates additional isoforms with an N‑terminal truncation or variable length deletions in the ECD. IL‑15 R alpha binds to Interleukin‑15 with high affinity (4). IL‑15 additionally interacts with lower affinity to a complex of IL‑2 R beta and the common gamma chain ( gamma c) which are also subunits of the IL‑2 receptor complex (5, 6). The use of shared receptor components contributes to the overlapping biological effects of IL‑15 and IL‑2. The dominant mechanism of IL‑15 action is known as transpresentation in which IL‑15/IL‑15 R alpha complexes are expressed on the surface of one cell and interact with complexes of IL‑2 R beta / gamma c on adjacent cells (7). This enables cells to respond to IL‑15 even if they do not express IL‑15 R alpha (8 ‑ 10). IL‑15/IL‑15 R alpha complexes can transmit reverse signaling that promotes cellular adhesion, tyrosine phosphorylation of intracellular proteins, and cytokine secretion by the IL‑15/IL‑15 R alpha expressing cells (11, 12). Shed soluble forms of IL‑15 R alpha retain the ability to bind tightly to IL‑15 and can inhibit IL‑15 bioactivity (4, 13, 14).

References
  1. Ma, A. et al. (2006) Annu. Rev. Immunol. 24:657.
  2. Di Sabatino, A. et al. (2011) Cytokine Growth Factor Rev. 22:19.
  3. Budagian, V. et al. (2006) Cytokine Growth Factor Rev. 17:259.
  4. Giri, J.G. et al. (1995) EMBO 14:3654.
  5. Grabstein, K. et al. (1994) Science 264:965.
  6. Giri, J. et al. (1994) EMBO J. 13:2822.
  7. Stonier, S.W. and K.S. Schluns (2010) Immunol. Lett. 127:85.
  8. Duitman, E.H. et al. (2008) Mol. Cell. Biol. 28:4851.
  9. Dubois, S. et al. (2002) Immunity 17:537.
  10. Burkett, P.R. et al. (2004) J. Exp. Med. 200:825.
  11. Budagian, V. et al. (2004) J. Biol. Chem. 279:42192.
  12. Neely, G.G. et al. (2004) J. Immunol. 172:4225.
  13. Budagian, V. et al. (2004) J. Biol. Chem. 279:40368.
  14. Mortier, E. et al. (2004) J. Immunol. 173:1681.
Long Name
Interleukin 15 Receptor alpha
Entrez Gene IDs
3601 (Human); 16169 (Mouse); 102121571 (Cynomolgus Monkey)
Alternate Names
CD215 antigen; CD215; IL15 R alpha; IL-15 R alpha; IL-15 receptor subunit alpha; IL-15R alpha; IL15RA; IL-15Ra; IL-15R-alpha; interleukin 15 receptor, alpha; interleukin-15 receptor subunit alpha; MGC104179

Citations for Recombinant Mouse IL-15R alpha Fc Chimera Protein, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

41 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity
    Authors: Kang, S;Mansurov, A;Kurtanich, T;Chun, HR;Slezak, AJ;Volpatti, LR;Chang, K;Wang, T;Alpar, AT;Refvik, KC;Hansen, OI;Borjas, GJ;Shim, HN;Hultgren, KT;Gomes, S;Solanki, A;Ishihara, J;Swartz, MA;Hubbell, JA;
    Science advances
    Species: Mouse
    Sample Types: Whole Cell
    Applications: Cell Culture
  2. CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury
    Authors: Santos, J;Wang, P;Shemesh, A;Liu, F;Tsao, T;Aguilar, OA;Cleary, SJ;Singer, JP;Gao, Y;Hays, SR;Golden, J;Leard, LE;Kleinhenz, ME;Kolaitis, NA;Shah, RJ;Venado, A;Kukreja, J;Weigt, SS;Belperio, JA;Lanier, LL;Looney, MR;Greenland, JR;Calabrese, DR;
    JCI insight
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  3. Cytotoxic CD4 development requires CD4 effectors to concurrently recognize local antigen and encounter type I IFN-induced IL-15
    Authors: Devarajan, P;Vong, AM;Castonguay, CH;Silverstein, NJ;Kugler-Umana, O;Bautista, BL;Kelly, KA;Luban, J;Swain, SL;
    Cell reports
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  4. Tyrosine kinase inhibition alters intratumoral CD8+ T-cell subtype composition and activity
    Authors: AD Tieniber, AN Hanna, BD Medina, GA Vitiello, MS Etheringto, M Liu, KJ Do, F Rossi, RP DeMatteo
    Cancer Immunology Research, 2022-10-04;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  5. Differential controls of MAIT cell effector polarization by mTORC1/mTORC2 via integrating cytokine and costimulatory signals
    Authors: H Tao, Y Pan, S Chu, L Li, J Xie, P Wang, S Zhang, S Reddy, JW Sleasman, XP Zhong
    Nature Communications, 2021-04-01;12(1):2029.
    Species: Mouse
    Sample Types: Protein
    Applications: Bioassay
  6. The NK cell granule protein NKG7 regulates cytotoxic granule exocytosis and inflammation
    Authors: SS Ng, F De Labasti, J Yan, D Corvino, I Das, P Zhang, R Kuns, SB Chauhan, J Hou, XY Li, TCM Frame, BA McEnroe, E Moore, J Na, JA Engel, MSF Soon, B Singh, AJ Kueh, MJ Herold, M Montes de, SS Singh, PT Bunn, AR Aguilera, M Casey, M Braun, N Ghazanfari, S Wani, Y Wang, FH Amante, CL Edwards, A Haque, WC Dougall, OP Singh, AG Baxter, MWL Teng, A Loukas, NL Daly, N Cloonan, MA Degli-Espo, J Uzonna, WR Heath, T Bald, SK Tey, K Nakamura, GR Hill, R Kumar, S Sundar, MJ Smyth, CR Engwerda
    Nat. Immunol., 2020-08-24;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Bioassay
  7. Allogeneic FLT3 CAR T Cells with an Off-Switch Exhibit Potent Activity against AML and Can Be Depleted to Expedite Bone Marrow Recovery
    Authors: C Sommer, HY Cheng, D Nguyen, D Dettling, YA Yeung, J Sutton, M Hamze, J Valton, J Smith, I Djuretic, J Chaparro-R, BJ Sasu
    Mol. Ther., 2020-06-19;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Bioassay
  8. Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells
    Authors: M Yu, H Pan, N Che, L Li, C Wang, Y Wang, G Ma, M Qian, J Liu, M Zheng, H Xie, L Ling, Y Zhao, X Guan, Q Ding, W Zhou, S Wang
    Cell. Mol. Immunol., 2020-05-08;0(0):.
    Species: Mouse
    Sample Types:
    Applications: In Vivo
  9. Diversity in medullary thymic epithelial cells controls the activity and availability of iNKT cells
    Authors: B Lucas, AJ White, EJ Cosway, SM Parnell, KD James, ND Jones, I Ohigashi, Y Takahama, WE Jenkinson, G Anderson
    Nat Commun, 2020-05-04;11(1):2198.
    Species: Mouse
    Sample Types: In Vivo, Whole Cells
    Applications: Bioassay, In Vivo
  10. Design and characterisation of a novel interleukin-15 receptor alpha fusion protein and analysis of interleukin-15 complexation
    Authors: AS Schmid, D Neri
    PLoS ONE, 2019-07-26;14(7):e0219313.
    Species: Mouse
    Sample Types: Recombinant Protein, Whole Cells
    Applications: Bioassay, Size Exclusion Chromatography
  11. Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway
    Authors: M Alvarez, F Simonetta, J Baker, A Pierini, AS Wenokur, AR Morrison, WJ Murphy, RS Negrin
    JCI Insight, 2019-06-18;5(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  12. NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity
    Authors: N Simonovi?, A Witalisz-S, K Meissl, C Lassnig, U Reichart, T Kolbe, M Farlik, C Bock, V Sexl, M Müller, B Strobl
    J. Immunol., 2019-02-04;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  13. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells
    Authors: KS Burrack, MA Huggins, E Taras, P Dougherty, CM Henzler, R Yang, S Alter, EK Jeng, HC Wong, M Felices, F Cichocki, JS Miller, GT Hart, AJ Johnson, SC Jameson, SE Hamilton
    Immunity, 2018-04-03;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  14. Frequencies of IL-15R?+ cells in patients with Beh�et's disease and the effects of overexpressing IL-15R?+ on disease symptoms in mice
    Authors: SMS Islam, B Choi, J Choi, ES Lee, S Sohn
    Cytokine, 2018-02-01;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  15. Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1
    Authors: JH DeLong, AO Hall, C Konradt, GM Coppock, J Park, G Harms Prit, CA Hunter
    J. Immunol., 2018-01-22;0(0):.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  16. IL-15 Complexes Induce Migration of Resting Memory CD8 T Cells into Mucosal Tissues
    Authors: RT Sowell, JW Goldufsky, M Rogozinska, Z Quiles, Y Cao, EF Castillo, A Finnegan, AL Marzo
    J. Immunol., 2017-08-16;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  17. Primary tumors limit metastasis formation through induction of IL15-mediated crosstalk between patrolling monocytes and NK cells
    Authors: H Kubo, S Mensurado, N Goncalves-, K Serre, B Silva-Sant
    Cancer Immunol Res, 2017-08-15;0(0):.
    Species: Mouse
    Sample Types: Tissue Culture Supernates
    Applications: Bioassay
  18. NKG2D stimulation of CD8+ T cells during priming promotes their capacity to produce cytokines in response to viral infection in mice
    Authors: I Kavazovi?, M Lenarti?, V Jelen?i?, S Jurkovi?, NA Lemmermann, S Jonji?, B Poli?, FM Wensveen
    Eur. J. Immunol., 2017-05-02;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  19. IL-15 Enables Septic Shock by Maintaining NK Cell Integrity and Function
    Authors: Yin Guo
    J. Immunol, 2016-12-28;0(0):.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  20. IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection.
    Authors: Patil N, Luan L, Bohannon J, Guo Y, Hernandez A, Fensterheim B, Sherwood E
    PLoS ONE, 2016-02-09;11(2):e0148452.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  21. Differential Responsiveness of Innate-like IL-17- and IFN-gamma-Producing gammadelta T Cells to Homeostatic Cytokines.
    Authors: Corpuz T, Stolp J, Kim H, Pinget G, Gray D, Cho J, Sprent J, Webster K
    J Immunol, 2015-12-16;196(2):645-54.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  22. IL-15 Superagonist-Mediated Immunotoxicity: Role of NK Cells and IFN-gamma.
    Authors: Guo Y, Luan L, Rabacal W, Bohannon J, Fensterheim B, Hernandez A, Sherwood E
    J Immunol, 2015-07-27;195(5):2353-64.
    Species: Mouse
    Sample Types: Recombinant Protein
    Applications: Bioassay
  23. TRAF2 regulates peripheral CD8(+) T-cell and NKT-cell homeostasis by modulating sensitivity to IL-15.
    Authors: Villanueva J, Malle E, Gardam S, Silveira P, Zammit N, Walters S, Brink R, Grey S
    Eur J Immunol, 2015-05-26;45(6):1820-31.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  24. IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Ralpha production.
    Authors: Yokota S, Yoshida O, Dou L, Spadaro A, Isse K, Ross M, Stolz D, Kimura S, Du Q, Demetris A, Thomson A, Geller D
    J Immunol, 2015-05-11;194(12):6045-56.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  25. The natural killer cell dysfunction of aged mice is due to the bone marrow stroma and is not restored by IL-15/IL-15Ralpha treatment.
    Authors: Nair S, Fang M, Sigal L
    Aging Cell, 2014-11-16;14(2):180-90.
    Species: Mouse
    Sample Types:
    Applications: In Vivo
  26. Bim controls IL-15 availability and limits engagement of multiple BH3-only proteins.
    Authors: Kurtulus S, Sholl A, Toe J, Tripathi P, Raynor J, Li K, Pellegrini M, Hildeman D
    Cell Death Differ, 2014-08-15;22(1):174-84.
    Species: Mouse
    Sample Types: Whole Organism
    Applications: In Vivo
  27. Differential requirement for CCR4 and CCR7 during the development of innate and adaptive alphabetaT cells in the adult thymus.
    Authors: Cowan J, McCarthy N, Parnell S, White A, Bacon A, Serge A, Irla M, Lane P, Jenkinson E, Jenkinson W, Anderson G
    J Immunol, 2014-07-02;193(3):1204-12.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  28. An essential role for medullary thymic epithelial cells during the intrathymic development of invariant NKT cells.
    Authors: White A, Jenkinson W, Cowan J, Parnell S, Bacon A, Jones N, Jenkinson E, Anderson G
    2014-02-07;0(0):.
    Species: Mouse
    Sample Types: Recombinant Protein
    Applications: Enzyme Assay
  29. Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation.
    Authors: Levanon, Ditsa, Negreanu, Varda, Lotem, Joseph, Bone, Karen Ra, Brenner, Ori, Leshkowitz, Dena, Groner, Yoram
    Mol Cell Biol, 2014-01-13;34(6):1158-69.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  30. Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim.
    Authors: Kurtulus S, Tripathi P, Moreno-Fernandez ME
    J. Immunol., 2011-03-30;186(10):5729-37.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  31. A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection.
    Authors: Verbist KC, Cole CJ, Field MB, Klonowski KD
    J. Immunol., 2010-11-22;186(1):174-82.
    Species: Mouse
    Sample Types: In Vivo, Whole Cells
    Applications: Bioassay, In Vivo
  32. Thymic and peripheral microenvironments differentially mediate development and maturation of iNKT cells by IL-15 transpresentation.
    Authors: Castillo EF, Acero LF, Stonier SW, Zhou D, Schluns KS
    Blood, 2010-06-25;116(14):2494-503.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  33. A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice.
    Authors: Suwanai H, Wilcox MA, Mathis D, Benoist C
    Proc. Natl. Acad. Sci. U.S.A., 2010-05-03;107(20):9305-10.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  34. Self-specific CD8+ T cells maintain a semi-naive state following lymphopenia-induced proliferation.
    Authors: Johnson LD, Jameson SC
    J. Immunol., 2010-04-14;184(10):5604-11.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  35. Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells.
    Authors: Pepper M, Linehan JL, Pagan AJ, Zell T, Dileepan T, Cleary PP, Jenkins MK
    Nat. Immunol., 2009-11-22;11(1):83-9.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  36. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development.
    Authors: Vang KB, Yang J, Mahmud SA, Burchill MA, Vegoe AL, Farrar MA
    J. Immunol., 2008-09-01;181(5):3285-90.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  37. IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response.
    Authors: Rubinstein MP, Lind NA, Purton JF, Filippou P, Best JA, McGhee PA, Surh CD, Goldrath AW
    Blood, 2008-08-08;112(9):3704-12.
    Species: Mouse
    Sample Types: Recombinant Protein
    Applications: Stimulation
  38. Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells.
    Authors: Epardaud M, Elpek KG, Rubinstein MP, Yonekura AR, Bellemare-Pelletier A, Bronson R, Hamerman JA, Goldrath AW, Turley SJ
    Cancer Res., 2008-04-15;68(8):2972-83.
    Species: Mouse
    Sample Types: In Vivo
    Applications: In Vivo
  39. IL-15 regulates immature B-cell homing in an Ly49D-, IL-12, and IL-18 dependent manner.
    Authors: Hart G, Avin-Wittenberg T, Shachar I
    Blood, 2007-09-27;111(1):50-9.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Bioassay
  40. A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex.
    Authors: Rafei M, Wu JH, Annabi B, Lejeune L, Francois M, Galipeau J
    Blood, 2006-11-02;109(5):2234-42.
    Species: Mouse
    Sample Types: Peptide
    Applications: Surface Plasmon Resonance
  41. The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation-associated cytokines.
    Authors: Rhodes KE, Raivich G, Fawcett JW
    Neuroscience, 2006-04-21;140(1):87-100.
    Species: Rat
    Sample Types: In Vivo
    Applications: In Vivo

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs
Loading...

Reviews for Recombinant Mouse IL-15R alpha Fc Chimera Protein, CF

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Recombinant Mouse IL-15R alpha Fc Chimera Protein, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Recombinant Mouse IL-15 R alpha Fc Chimera Protein, CF
By jingbin wang on 05/24/2016
Application: In vivo study